Jaguar expects first results in Q2 2025 of proof-of-concept investigator-initiated trials of crofelemer for the rare diseases short bowel ...

Eisai Receives Regulatory Review Outcome for Lecanemab as a Treatment for Early Alzheimer's Disease in Australia TOKY ...

Iowa has the second highest incidence rate of cancer in the country, and it is already feeling Trump's cuts to the workforce ...

Lecanemab is the result of a strategic research alliance between Eisai and BioArctic. It is a humanized immunoglobulin gamma 1 (IgG1) monoclonal antibody directed against aggregated soluble ...

Q4 2024 Earnings Call Transcript March 4, 2025 Rigel Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $0.8, expectations were $0.3. Operator: Greetings, and welcome to Rigel ...

The Bureau of Animal Industry (BAI) is refining the guidelines on the bilateral recognition of bird flu regionalization to ...

Q4 2024 Earnings Conference Call March 4, 2025 4:30 PM ET. Company Participants. Ray Furey - Executive Vice President, General Counsel & ...

Ten UB PhD candidates will show off their research and communication skills on March 7 at the ninth annual Three Minute Thesis (3MT) competition. The contest will begin at 3 p.m. in the Screening Room ...

Wildlife officials are looking into a report of 20 dead ducks, geese and seagulls on a community beach in East Patchogue ...

With defocus contact lenses on the market, research into future myopia management techniques narrow in on defocus spectacles ...

A cluster of deaths linked to a mysterious illness in the Democratic Republic of the Congo could be the result of a poisoning ...

Implantation of drug-eluting stents (DESs) remains central to percutaneous coronary intervention (PCI) for acute coronary ...